LeadIQ logo
Learn more at LeadIQ.com

Insights

Leading Pharma Stock Akero Therapeutics has been recognized as the Best Performing Pharma stock in 2025 so far, indicating strong market performance and potential investor interest.

Investor Interest Proficio Capital Partners LLC recently invested $320,000 in Akero Therapeutics, displaying confidence in the company's growth and future prospects.

Expansion Opportunities Akero Therapeutics attended significant events like the EASL Congress 2025 and BofA Securities Health Care Conference, providing networking opportunities in the healthcare industry.

Innovative Medicines Akero Therapeutics is developing transformational treatments for patients with serious metabolic diseases, offering potential collaboration opportunities for healthcare providers seeking groundbreaking therapies.

Legal Developments While facing legal challenges, Akero Therapeutics has the opportunity to address issues, potentially leading to consulting or legal services partnerships in navigating regulatory matters.

Similar companies to Akero Therapeutics

Akero Therapeutics Tech Stack

Akero Therapeutics uses 8 technology products and services including MySQL, Twitter Emoji (Twemoji), Font Awesome, and more. Explore Akero Therapeutics's tech stack below.

  • MySQL
    Database
  • Twitter Emoji (Twemoji)
    Font Scripts
  • Font Awesome
    Font Scripts
  • Acquia Cloud Platform
    Platform As A Service
  • New Relic
    Real User Monitoring
  • Google
    Search Engines
  • Akamai Web Application Protector
    Security
  • Bootstrap
    UI Frameworks

Media & News

Akero Therapeutics's Email Address Formats

Akero Therapeutics uses at least 1 format(s):
Akero Therapeutics Email FormatsExamplePercentage
First@akerotx.comJohn@akerotx.com
32%
FLast@akerotx.comJDoe@akerotx.com
22%
Last@akerotx.comDoe@akerotx.com
14%
First@akerotx.comJohn@akerotx.com
32%

Frequently Asked Questions

Where is Akero Therapeutics's headquarters located?

Minus sign iconPlus sign iconAkero Therapeutics's main headquarters is located at 601 Gateway Blvd, Suite 350 South San Francisco, California 94080, US. The company has employees across 4 continents, including North AmericaEuropeAsia.

What is Akero Therapeutics's phone number?

Minus sign iconPlus sign icon You can contact Akero Therapeutics's main corporate office by phone at
+1-650-487-****
. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Akero Therapeutics's stock symbol?

Minus sign iconPlus sign iconAkero Therapeutics is a publicly traded company; the company's stock symbol is AKRO.

What is Akero Therapeutics's official website and social media links?

Minus sign iconPlus sign iconAkero Therapeutics's official website is akerotx.com and has social profiles on LinkedInCrunchbase.

How much revenue does Akero Therapeutics generate?

Minus sign iconPlus sign icon As of June 2025, Akero Therapeutics's annual revenue reached $7.5M.

What is Akero Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign iconAkero Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Akero Therapeutics have currently?

Minus sign iconPlus sign iconAs of June 2025, Akero Therapeutics has approximately 70 employees across 4 continents, including North AmericaEuropeAsia. Key team members include Chief Technical Officer: S. G.Chief Scientific Officer: T. R.Chief Operating Officer: D. S.. Explore Akero Therapeutics's employee directory with LeadIQ.

What industry does Akero Therapeutics belong to?

Minus sign iconPlus sign iconAkero Therapeutics operates in the Biotechnology Research industry.

What technology does Akero Therapeutics use?

Minus sign iconPlus sign iconAkero Therapeutics's tech stack includes MySQLTwitter Emoji (Twemoji)Font AwesomeAcquia Cloud PlatformNew RelicGoogleAkamai Web Application ProtectorBootstrap.

What is Akero Therapeutics's email format?

Minus sign iconPlus sign iconAkero Therapeutics's email format typically follows the pattern of . Find more Akero Therapeutics email formats with LeadIQ.

When was Akero Therapeutics founded?

Minus sign iconPlus sign iconAkero Therapeutics was founded in 2017.
Akero Therapeutics

Akero Therapeutics

Biotechnology ResearchUnited States51-200 Employees

Akero Therapeutics is a clinical-stage company developing transformational treatments for patients with serious metabolic diseases marked by high unmet medical need, including MASH. Akero's lead product candidate, EFX, is currently being evaluated in the ongoing SYMMETRY study, a 96-week Phase 2b clinical trial in patients with compensated cirrhosis due to MASH (F4 fibrosis), as well as three ongoing Phase 3 clinical trials in patients with pre-cirrhotic MASH or compensated cirrhosis due to MASH: SYNCHRONY Histology, SYNCHRONY Real-World, and SYNCHRONY Outcomes. The SYNCHRONY program builds on the results of two Phase 2b clinical trials, the HARMONY study in patients with pre-cirrhotic MASH (F2-F3) and the SYMMETRY study in patients with compensated cirrhosis due to MASH (F4). Akero is headquartered in South San Francisco.

Section iconCompany Overview

Headquarters
601 Gateway Blvd, Suite 350 South San Francisco, California 94080, US
Phone number
+1-650-487-****
Website
akerotx.com
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
AKRO
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2017
Employees
51-200

Section iconMedia & News

Section iconFunding & Financials

  • $10M

    Akero Therapeutics's revenue is in the range of $10M

Section iconFunding & Financials

  • $10M

    Akero Therapeutics's revenue is in the range of $10M

Company Leadership

  • Stylized image of a person
    S. G.
    Chief Technical Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    T. R.
    Chief Scientific Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    D. S.
    Chief Operating Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    T. R.
    Chief Scientific Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    D. V.
    Vice President Of Quality Assurance
    Phone icon
    Mobile Phone

Employee Directory

  • Stylized image of a person
    D. S.
    Chief Operating Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    S. E.
    Founder
    Phone icon
    Mobile Phone
  • Stylized image of a person
    T. R.
    Chief Scientific Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    P. L.
    Svp, Commercial Strategy
    Phone icon
    Mobile Phone
  • Stylized image of a person
    M. J.
    Vp, Clinical Development
    Phone icon
    Mobile Phone

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.